| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 18327670
[patent_doc_number] => RE049502
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2023-04-25
[patent_title] => Phenyl based compounds substituted with aldehyde moieties and their use in perfumery
[patent_app_type] => reissue
[patent_app_number] => 16/922570
[patent_app_country] => US
[patent_app_date] => 2020-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10835
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16922570
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/922570 | Phenyl based compounds substituted with aldehyde moieties and their use in perfumery | Jul 6, 2020 | Issued |
| 16/922978 | TREATMENT OF FIBROSIS USING FXR LIGANDS | Jul 6, 2020 | Abandoned |
Array
(
[id] => 18115658
[patent_doc_number] => RE049362
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2023-01-10
[patent_title] => Dye compounds and the use of their labelled conjugates
[patent_app_type] => reissue
[patent_app_number] => 16/917713
[patent_app_country] => US
[patent_app_date] => 2020-06-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16606
[patent_no_of_claims] => 72
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16917713
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/917713 | Dye compounds and the use of their labelled conjugates | Jun 29, 2020 | Issued |
Array
(
[id] => 18799389
[patent_doc_number] => RE049741
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2023-12-05
[patent_title] => Drug delivery system for administration of poorly water soluble pharmaceutically active substances
[patent_app_type] => reissue
[patent_app_number] => 16/899848
[patent_app_country] => US
[patent_app_date] => 2020-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 10
[patent_no_of_words] => 12123
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 184
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16899848
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/899848 | Drug delivery system for administration of poorly water soluble pharmaceutically active substances | Jun 11, 2020 | Issued |
| 16/886535 | DRUG-CONJUGATES, CONJUGATION METHODS, AND USES THEREOF | May 27, 2020 | Abandoned |
| 16/874444 | ANTI-VIRAL COMPOUNDS | May 13, 2020 | Abandoned |
| 16/872986 | ENHANCER OF ZESTE HOMOLG 2 INHIBITORS | May 11, 2020 | Abandoned |
Array
(
[id] => 18525010
[patent_doc_number] => RE049594
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2023-08-01
[patent_title] => Apelin receptor (APJ) agonists and uses thereof
[patent_app_type] => reissue
[patent_app_number] => 16/974363
[patent_app_country] => US
[patent_app_date] => 2020-05-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 30845
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 415
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16974363
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/974363 | Apelin receptor (APJ) agonists and uses thereof | May 3, 2020 | Issued |
Array
(
[id] => 16562692
[patent_doc_number] => RE048392
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2021-01-12
[patent_title] => Cyclic process for the production of taurine from alkali isethionate
[patent_app_type] => reissue
[patent_app_number] => 16/863384
[patent_app_country] => US
[patent_app_date] => 2020-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3668
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 165
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16863384
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/863384 | Cyclic process for the production of taurine from alkali isethionate | Apr 29, 2020 | Issued |
Array
(
[id] => 17405388
[patent_doc_number] => RE048928
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2022-02-15
[patent_title] => Lysophosphatidic acid detection
[patent_app_type] => reissue
[patent_app_number] => 16/858380
[patent_app_country] => US
[patent_app_date] => 2020-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 20
[patent_no_of_words] => 12985
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 423
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16858380
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/858380 | Lysophosphatidic acid detection | Apr 23, 2020 | Issued |
Array
(
[id] => 16474338
[patent_doc_number] => RE048333
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2020-12-01
[patent_title] => Process for producing taurine from alkali taurinates
[patent_app_type] => reissue
[patent_app_number] => 16/854406
[patent_app_country] => US
[patent_app_date] => 2020-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3488
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16854406
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/854406 | Process for producing taurine from alkali taurinates | Apr 20, 2020 | Issued |
Array
(
[id] => 16498291
[patent_doc_number] => RE048354
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2020-12-15
[patent_title] => Process for producing taurine from alkali taurinates
[patent_app_type] => reissue
[patent_app_number] => 16/854395
[patent_app_country] => US
[patent_app_date] => 2020-04-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3488
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16854395
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/854395 | Process for producing taurine from alkali taurinates | Apr 20, 2020 | Issued |
Array
(
[id] => 16351161
[patent_doc_number] => RE048238
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2020-10-06
[patent_title] => Process for producing taurine from alkali taurinates
[patent_app_type] => reissue
[patent_app_number] => 16/843272
[patent_app_country] => US
[patent_app_date] => 2020-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3488
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16843272
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/843272 | Process for producing taurine from alkali taurinates | Apr 7, 2020 | Issued |
| 16/842041 | LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | Apr 6, 2020 | Abandoned |
Array
(
[id] => 16531463
[patent_doc_number] => RE048369
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2020-12-29
[patent_title] => Process for producing taurine
[patent_app_type] => reissue
[patent_app_number] => 16/842389
[patent_app_country] => US
[patent_app_date] => 2020-04-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2480
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16842389
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/842389 | Process for producing taurine | Apr 6, 2020 | Issued |
Array
(
[id] => 17920924
[patent_doc_number] => RE049240
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2022-10-11
[patent_title] => Inhibitors of histone deacetylase
[patent_app_type] => reissue
[patent_app_number] => 16/815755
[patent_app_country] => US
[patent_app_date] => 2020-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 35
[patent_no_of_words] => 27944
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16815755
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/815755 | Inhibitors of histone deacetylase | Mar 10, 2020 | Issued |
| 90/014460 | NITRATE FORMULATIONS AND THEIR USE AS NITRIC OXIDE PRODRUGS | Feb 20, 2020 | Issued |
Array
(
[id] => 17725879
[patent_doc_number] => RE049128
[patent_country] => US
[patent_kind] => E1
[patent_issue_date] => 2022-07-12
[patent_title] => Hydroxyl purine compounds and applications thereof
[patent_app_type] => reissue
[patent_app_number] => 16/795419
[patent_app_country] => US
[patent_app_date] => 2020-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33769
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16795419
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/795419 | Hydroxyl purine compounds and applications thereof | Feb 18, 2020 | Issued |
| 16/751032 | Deuterated Compounds For Electronic Applications | Jan 22, 2020 | Pending |
| 96/000311 | IMAGING AGENTS FOR DETECTING NEUROLOGICAL DYSFUNCTION | Jan 13, 2020 | Pending |